WJ, C., SY, L., M, C., LC, C., HO, H., KH, C., & MT, S. (2021). Active Tumoral/Tumor Environmental Dual-Targeting by Non-Covalently Arming with Trispecific Antibodies or Dual-Bispecific Antibodies on Docetaxel-Loaded mPEGylated Nanocarriers to Enhance Chemotherapeutic Efficacy and Minimize Systemic Toxicity. Dove Medical Press.
Style de citation Chicago (17e éd.)WJ, Cheng, Lin SY, Chen M, Chen LC, Ho HO, Chuang KH, et Sheu MT. Active Tumoral/Tumor Environmental Dual-Targeting by Non-Covalently Arming with Trispecific Antibodies or Dual-Bispecific Antibodies on Docetaxel-Loaded MPEGylated Nanocarriers to Enhance Chemotherapeutic Efficacy and Minimize Systemic Toxicity. Dove Medical Press, 2021.
Style de citation MLA (8e éd.)WJ, Cheng, et al. Active Tumoral/Tumor Environmental Dual-Targeting by Non-Covalently Arming with Trispecific Antibodies or Dual-Bispecific Antibodies on Docetaxel-Loaded MPEGylated Nanocarriers to Enhance Chemotherapeutic Efficacy and Minimize Systemic Toxicity. Dove Medical Press, 2021.